Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 501.50M | 537.72M | 687.41M | 614.30M | 503.01M |
Gross Profit | 147.50M | 164.61M | 168.45M | 170.23M | 134.11M |
EBITDA | -52.06M | -75.65M | -161.41M | -214.71M | -101.65M |
Net Income | -83.05M | -154.65M | -241.97M | -296.54M | -196.43M |
Balance Sheet | |||||
Total Assets | 1.26B | 1.40B | 934.45M | 946.85M | 954.64M |
Cash, Cash Equivalents and Short-Term Investments | 797.70M | 856.13M | 351.76M | 364.91M | 419.87M |
Total Debt | 574.47M | 603.44M | 573.44M | 456.28M | 446.23M |
Total Liabilities | 892.31M | 964.28M | 1.38B | 1.21B | 1.09B |
Stockholders Equity | 363.31M | 428.14M | -451.98M | -274.55M | -132.99M |
Cash Flow | |||||
Free Cash Flow | 21.56M | -24.42M | -81.17M | -101.77M | -124.13M |
Operating Cash Flow | 21.56M | -20.16M | -73.83M | -83.38M | -17.30M |
Investing Cash Flow | 110.45M | -146.60M | -8.45M | -5.47M | -195.16M |
Financing Cash Flow | -56.56M | 504.77M | 64.62M | 64.90M | 216.29M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | HK$20.97B | 39.23 | 28.81% | 0.71% | 14.99% | 31.70% | |
61 Neutral | HK$17.74B | 5.78 | -7.44% | 3.51% | 11.55% | -28.15% | |
53 Neutral | HK$1.45B | ― | -18.19% | ― | -24.50% | -93.44% | |
53 Neutral | HK$790.49M | ― | -18.64% | ― | 41.62% | -22.27% | |
50 Neutral | HK$3.26B | ― | -2.19% | ― | 5.32% | 89.43% | |
45 Neutral | HK$5.95B | ― | -2.97% | ― | 11.00% | 56.87% | |
44 Neutral | HK$799.78M | ― | ― | ― | ― |
Xikang Cloud Hospital Holdings Inc. announced the grant of 28,990,000 share options to 236 eligible participants under its Post-IPO Share Option Scheme. The options, which have an exercise price of HK$0.904 per share, are subject to a vesting schedule over three years and performance targets based on financial and business-related indicators. The scheme includes a clawback mechanism for violations of laws or company rules, ensuring alignment with company goals and stakeholder interests.
Xikang Cloud Hospital Holdings Inc. announced its decision to use idle proceeds from its global offering for cash management by investing in high-security, liquid wealth management products. This strategic move, involving up to US$40 million, is intended to enhance fund usage efficiency and protect shareholder interests without affecting the company’s normal operations or the intended use of proceeds.
Xikang Cloud Hospital Holdings Inc. held its Annual General Meeting on May 22, 2025, where all proposed resolutions were passed. These included the adoption of financial statements, re-election of directors, re-appointment of auditors, and granting mandates for share issuance and repurchase. The adoption of the ninth amended Memorandum and Articles of Association was also approved, indicating strategic governance updates.
Xikang Cloud Hospital Holdings Inc. announced a connected transaction involving the disposal of equity interests in a target company and a capital increase arrangement. Xikang Healthcare Technology, a subsidiary of Xikang Cloud Hospital, agreed to transfer its equity interest in the target company to Neutech, while Neutech will also participate in a capital increase for the target company. This transaction will result in a dilution of Xikang Cloud Hospital’s shareholding in the target company, and it complies with the reporting requirements under the Listing Rules, though it is exempt from independent shareholders’ approval.